SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
Recruiting · NCT07198165 · Registry updated 2025-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm, rectum adenocarcinoma | Recruiting | Phase 2 | 2025-09-30 | NCT07198165 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ruijin Hospital | 454 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ruijin Hospital, Shanghai Jiaotong University School of Medicine | Shanghai | China | 21 |